DAVID PARRILLO, MBA – CBSET SR. ACCOUNT EXEC., BUSINESS DEVELOPMENT

CELEBRATING 5 YEARS AT CBSET…David joined CBSET in 2017 as Senior Account Executive for Business Development. He has 30 years of biotech and pharma sales experience in therapeutic areas ranging from cardiology, infertility, and oncology to allergy/immunology and patient-reported outcomes. Previous employers include Bristol Meyers Squibb, EMD Serono and Schering-Plough, working within the major academic […]

RAMI TZAFRIRI, PhD – CBSET DIRECTOR OF RESEARCH & INNOVATION

CELEBRATING 12 YEARS AT CBSET… Dr. Rami Tzafriri provides scientific leadership to CBSET’s cutting-edge translational research programs, leveraging CBSET’s strengths in minimally invasive interventions, histopathology, imaging, bioanalysis and computational modeling to accelerate product development. He also leads CBSET’s educational and technology differentiations mission, and liaises with key opinion leaders. THREE THINGS YOU SHOULD KNOW ABOUT […]

BRETT G. ZANI, PhD – CBSET DIRECTOR OF APPLIED SCIENCES

CELEBRATING 12 YEARS AT CBSET… Dr. Brett Zani joined the CBSET team in 2010. His biomedical research background ranges from molecular cardiology and cancer biology to cardiovascular physiology and tissue regeneration. He holds an MS and PhD in Cellular and Integrative Physiology from Indiana University School of Medicine. TWO THINGS YOU SHOULD KNOW ABOUT DR. […]

MICHAEL NAIMARK, MS – CBSET DIRECTOR OF BUSINESS DEVELOPMENT

CELEBRATING 6 YEARS AT CBSET… Michael joined CBSET in 2016 as Director of Business Development, bringing significant biomedical experience and specialized expertise to the role. Previously, he was employed by Neural Stem Cell Institute (NSCI), where he oversaw development of a cell-based therapy for macular degeneration under an award from the New York Stem Cell […]

RAMI TZAFRIRI, PhD – CBSET DIRECTOR OF RESEARCH & INNOVATION

CELEBRATING 12 YEARS AT CBSET… Dr. Rami Tzafriri provides scientific leadership to CBSET’s cutting-edge translational research programs, leveraging CBSET’s strengths in minimally invasive interventions, histopathology, imaging, bioanalysis and computational modeling to accelerate product development. He also leads CBSET’s educational and technology differentiations mission, and liaises with key opinion leaders. THREE THINGS YOU SHOULD KNOW ABOUT […]

DR. JOHN KEATING, DVM, DACVP – CBSET DIRECTOR OF PATHOLOGY

CELEBRATING 12 YEARS AT CBSET… Dr. John Keating is a Diplomate of the American College of Veterinary Pathology, with years of experience in contract research and preclinical safety evaluations, including gross and microscopic pathology, pathophysiology, specialized staining, and imaging procedures across a variety of device classes and large- and small-animal species, and is well-versed in […]

PETER M. MARKHAM, MS – CBSET PRESIDENT, CEO, CO-FOUNDER

CELEBRATING 16 YEARS AT CBSET… With broad scientific expertise in both drug and device development, Peter co-founded CBSET in 2006 and, as its CEO, has since led the way in establishing CBSET as the undisputed gold standard for preclinical science in the life sciences industry. THREE THINGS YOU SHOULD KNOW ABOUT PETER M. MARKHAM 1: […]

FOCUS ON MECHANICAL THROMBECTOMY

Ischemic stroke represents the fifth most common cause of death in the western world and the number one cause of long-term disability. Systemic intravenous fibrinolysis, the prevailing gold standard in stroke therapy, is limited by strict timing parameters and modes efficacy in large strokes caused by clots in the proximal cerebral vasculature. Since 2015 multiple […]

SCANNING ELECTRON MICROSCOPY (SEM)

CBSET offers Scanning Electron Microscopy (SEM) services that complement our other services, including in-life studies, pathology services, and mechanical testing. We combine our advanced SEM techniques and experience in pathology and regulatory review to meet the critical needs of our clients, including assessment of tissue and material characterization after in vivo device treatments, investigation of device integrity […]